際際滷shows by User: MostafaAshraf37 / http://www.slideshare.net/images/logo.gif 際際滷shows by User: MostafaAshraf37 / Mon, 14 Dec 2020 22:29:04 GMT 際際滷Share feed for 際際滷shows by User: MostafaAshraf37 Ijsrp p10758 /MostafaAshraf37/ijsrp-p10758 ijsrp-p10758-201214222904
Cancer is one of the most challenging diseases and up until now. One of the most challenging things about cancer treatment is not the cure itself but the differentiation between the tumor cells and the normal cells. Most of the medical treatments of the cancer today cannot differentiate between the cancer cells and the normal one as well as it damages the hall tissue and it is still considered as a low-effect treatment to be applied in cancer. One of the most popular treatments of this kind is chemotherapy which is known for damaging the hall cells, cancer, and normal ones. Our research is focusing on generating a new therapy that can target the cancer cell itself so it will give us more efficiency ratio to stop cancer and will keep the other cells without any damage. We will use an antibody body for the protein antigen ErbB-2 which is located rabidly in the lung cancer cells' membrane surface. These antibodies will be produced by the immune system so it will target the tumor cells especially and stop the cell growth and damage it in some cases.]]>
Cancer is one of the most challenging diseases and up until now. One of the most challenging things about cancer treatment is not the cure itself but the differentiation between the tumor cells and the normal cells. Most of the medical treatments of the cancer today cannot differentiate between the cancer cells and the normal one as well as it damages the hall tissue and it is still considered as a low-effect treatment to be applied in cancer. One of the most popular treatments of this kind is chemotherapy which is known for damaging the hall cells, cancer, and normal ones. Our research is focusing on generating a new therapy that can target the cancer cell itself so it will give us more efficiency ratio to stop cancer and will keep the other cells without any damage. We will use an antibody body for the protein antigen ErbB-2 which is located rabidly in the lung cancer cells' membrane surface. These antibodies will be produced by the immune system so it will target the tumor cells especially and stop the cell growth and damage it in some cases.]]> Mon, 14 Dec 2020 22:29:04 GMT /MostafaAshraf37/ijsrp-p10758 MostafaAshraf37@slideshare.net(MostafaAshraf37) Ijsrp p10758 MostafaAshraf37 Cancer is one of the most challenging diseases and up until now. One of the most challenging things about cancer treatment is not the cure itself but the differentiation between the tumor cells and the normal cells. Most of the medical treatments of the cancer today cannot differentiate between the cancer cells and the normal one as well as it damages the hall tissue and it is still considered as a low-effect treatment to be applied in cancer. One of the most popular treatments of this kind is chemotherapy which is known for damaging the hall cells, cancer, and normal ones. Our research is focusing on generating a new therapy that can target the cancer cell itself so it will give us more efficiency ratio to stop cancer and will keep the other cells without any damage. We will use an antibody body for the protein antigen ErbB-2 which is located rabidly in the lung cancer cells' membrane surface. These antibodies will be produced by the immune system so it will target the tumor cells especially and stop the cell growth and damage it in some cases. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ijsrp-p10758-201214222904-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Cancer is one of the most challenging diseases and up until now. One of the most challenging things about cancer treatment is not the cure itself but the differentiation between the tumor cells and the normal cells. Most of the medical treatments of the cancer today cannot differentiate between the cancer cells and the normal one as well as it damages the hall tissue and it is still considered as a low-effect treatment to be applied in cancer. One of the most popular treatments of this kind is chemotherapy which is known for damaging the hall cells, cancer, and normal ones. Our research is focusing on generating a new therapy that can target the cancer cell itself so it will give us more efficiency ratio to stop cancer and will keep the other cells without any damage. We will use an antibody body for the protein antigen ErbB-2 which is located rabidly in the lung cancer cells&#39; membrane surface. These antibodies will be produced by the immune system so it will target the tumor cells especially and stop the cell growth and damage it in some cases.
Ijsrp p10758 from MostafaAshraf37
]]> 58 0 https://cdn.slidesharecdn.com/ss_thumbnails/ijsrp-p10758-201214222904-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 https://public.slidesharecdn.com/v2/images/profile-picture.png